Final exercise of subscription shares

RNS Number : 2116V
Schroder AsiaPacific Fund PLC
09 January 2013
 

 

9 January 2013

 

Final exercise of subscription shares

 

 

Further to the announcement on 2 January 2013 regarding the temporary suspension of the subscription share listing on the Official List the Board of Schroder AsiaPacific Fund plc (the "Company") announces that on the final exercise date of 31 December 2012, holders of 3,776,236 subscription shares exercised their rights to subscribe for ordinary shares at 245 pence per ordinary share.

 

In addition, the Board has been informed by the trustee, appointed pursuant to paragraph 8(g) of Part 4 of the Particulars and Procedures in respect of the subscription shares (set out in the prospectus of the Company dated 18 September 2009 relating to the subscription shares), that it has exercised all of the 24,667,291 outstanding subscription shares on the same terms and sold them in the market.

 

Subscription shareholders on whose behalf the trustee has exercised rights and sold the resulting ordinary shares will receive the net proceeds of such sale over the subscription price, less associated fees, costs and expenses expected to be approximately 0.68 pence per subscription share no later than 25 February 2013 provided that aggregate entitlements per holder of under £5.00 shall be retained for the benefit of the Company.

 

Following the issue of ordinary shares noted above the Company's issued share capital consists of 169,700,716 ordinary shares of 10p each, with each share carrying the right to one vote. The Company does not hold any shares in treasury; the total number of voting rights in the Company is therefore 169,700,716. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

 

 

Enquiries:

 

John Spedding

Schroder Investment Management Limited

020 7658 3206


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGGMNLGGFZM
UK 100

Latest directors dealings